cll14: venetoclax plus obinutuzumab for cll
Published 3 years ago • 968 plays • Length 5:54Download video MP4
Download video MP3
Similar videos
-
1:24
venetoclax plus obinutuzumab in ckt cll: analysis from the cll14 trial
-
2:03
venetoclax and obinutuzumab combination therapy for cll
-
1:43
six-year update from cll14: fixed-duration venetoclax obinutuzumab for previously untreated cll
-
10:24
fixed-duration therapy with venetoclax-obinutuzumab in frontline cll
-
0:59
5-year follow-up results of cll14: obinutuzumab venetoclax vs obinutuzumab chlorambucil in cll
-
1:01:22
what's new in cll - dr helen marr
-
3:06
mechanism of action of venetoclax (abt-199) and its side effects
-
4:52
apoptosis and venetoclax
-
1:16
cll14: venetoclax-obinutuzumab improves pfs and mrd in untreated, reduced fitness cll
-
1:32
cll14: feasibility of fixed-duration frontline therapy in cll
-
4:30
cll14 trial: obinutuzumab venetoclax vs obinutuzumab chlorambucil
-
0:48
venetoclax and obinutuzumab for cll
-
5:59
6-year results of cll14: venetoclax-obinutuzumab for previously untreated cll
-
3:22
combining venetoclax and obinutuzumab in the treatment of cll
-
0:45
obinutuzumab and venetoclax for high-risk cll: upcoming cll14 trial
-
1:35
cll: venetoclax in combination with obinutuzumab
-
3:15
overview of a phase ib study of venetoclax and obinutuzumab in cll
-
2:00
venetoclax plus rituximab or obinutuzumab in cll after allohct
-
3:07
cll14 trial analysis
-
2:08
the role of venetoclax in the treatment of cll
-
2:11
atezolizumab with venetoclax and obinutuzumab in patients with cll
-
1:14
cll14 trial thoughts